Performance of antisaccades in patients with cerebral small vessel disease accompanied by white matter hyperintensities

References

• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi: 10.1016/S1474-4422(10)70104-6
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. doi: 10.1016/S1474-4422(13)70124-8
   PubMed Web of Science ®Google Scholar
• Sharma R, Sekhon S, Lui F, Cascella M. White matter lesions. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
   Google Scholar
• Schmidt R, Enzinger C, Ropele S, et al. Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis. J Neurolog Sci. 2006;245(1–2):3–7. doi: 10.1016/j.jns.2005.06.018
   PubMedGoogle Scholar
• Lampe L, Kharabian-Masouleh S, Kynast J, et al. Lesion location matters: the relationships between white matter hyperintensities on cognition in the healthy elderly. J Cereb Blood Flow Metab. 2019;39(1):36–43. doi: 10.1177/0271678X17740501
   PubMed Web of Science ®Google Scholar
• den Berg EV, Geerlings MI, Biessels GJ, et al. White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer’s disease: a domain-specific meta-analysis. J Alzheimers Dis : JAD. 2018;63(2):515–527. doi: 10.3233/JAD-170573
   PubMedGoogle Scholar
• Kuang H, Zhou ZF, Zhu YG, et al. Pharmacological treatment of vascular dementia: a molecular mechanism perspective. Aging Dis. 2021;12(1):308–326. doi: 10.14336/AD.2020.0427
   PubMed Web of Science ®Google Scholar
• Thakkar N, Martis PB, Kutikuppala LVS, et al. Lecanemab: a hope in the management of Alzheimer’s disease. Brain Circ. 2023;9(3):194–195. doi: 10.4103/bc.bc_10_23
   PubMedGoogle Scholar
• Guo M, Sun L. From rodents to humans: rodent behavioral paradigms for social behavioral disorders. Brain Circ. 2023;9(3):154–161. doi: 10.4103/bc.bc_48_23
   PubMedGoogle Scholar
• Edwards I, Singh I, Rose, et al. The role of cortisol in the development of post-stroke dementia: a narrative review. Heart And Mind. 2022;6(3):151–158. doi: 10.4103/hm.hm_32_22
   Google Scholar
• Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43(3):302–313. doi: 10.1111/j.1469-8986.2006.00403.x
   PubMed Web of Science ®Google Scholar
• Munoz DP, Everling S. Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci. 2004;5(3):218–228. doi: 10.1038/nrn1345
   PubMed Web of Science ®Google Scholar
• Talanow T, Kasparbauer AM, Steffens M, et al. Facing competition: neural mechanisms underlying parallel programming of antisaccades and prosaccades. Brain Cogn. 2016;107:37–47. doi: 10.1016/j.bandc.2016.05.006
   PubMedGoogle Scholar
• Hutton SB. Cognitive control of saccadic eye movements. Brain Cogn. 2008;68(3):327–340. doi: 10.1016/j.bandc.2008.08.021
   PubMed Web of Science ®Google Scholar
• Heuer HW, Mirsky JB, Kong EL, et al. Antisaccade task reflects cortical involvement in mild cognitive impairment. Neurology. 2013;81(14):1235–1243. doi: 10.1212/WNL.0b013e3182a6cbfe
   PubMed Web of Science ®Google Scholar
• Webb B, Humphreys D, Heath M. Oculomotor executive dysfunction during the early and later stages of sport-related concussion recovery. J Neurotrauma. 2018;35(16):1874–1881. doi: 10.1089/neu.2018.5673
   PubMedGoogle Scholar
• Fielding J, Kilpatrick T, Millist L, et al. Antisaccade performance in patients with multiple sclerosis. Cortex. 2009;45(7):900–903. doi: 10.1016/j.cortex.2009.02.016
   PubMed Web of Science ®Google Scholar
• Fielding J, Kilpatrick T, Millist L, et al. Longitudinal assessment of antisaccades in patients with multiple sclerosis. PLOS ONE. 2012;7(2):e30475. doi: 10.1371/journal.pone.0030475
   PubMedGoogle Scholar
• Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the mini-mental state examination by age and educational level. JAMA. 1993;269(18):2386–2391. doi: 10.1001/jama.1993.03500180078038
   PubMed Web of Science ®Google Scholar
• Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922–935. doi: 10.1111/j.1532-5415.1992.tb01992.x
   PubMed Web of Science ®Google Scholar
• Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021;268(5):1615–1622. doi: 10.1007/s00415-019-09506-7
   PubMed Web of Science ®Google Scholar
• Tan SZK, Zhao RC, Chakrabarti S, et al. Interdisciplinary research in Alzheimer’s disease and the roles international societies can play. Aging Dis. 2021;12(1):36–41. doi: 10.14336/AD.2020.0602
   PubMedGoogle Scholar
• Zhao RC, Stambler I. The urgent need for international action for anti-aging and disease prevention. Aging Dis. 2020;11(1):212–215. doi: 10.14336/AD.2019.1230
   PubMedGoogle Scholar
• Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR. 1987;149(2):351–356. doi: 10.2214/ajr.149.2.351
   PubMed Web of Science ®Google Scholar
• Schramm S, Schliephake L, Himpfen H, et al. Vitamin D and white matter hyperintensities: results of the population-based Heinz Nixdorf recall study and 1000BRAINS. Eur J Neurol. 2021;28(6):1849–1858. doi: 10.1111/ene.14810
   PubMedGoogle Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi: 10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Botvinick MM, Braver TS, Barch DM, et al. Conflict monitoring and cognitive control. Psychol Rev. 2001;108(3):624–652. doi: 10.1037/0033-295X.108.3.624
   PubMed Web of Science ®Google Scholar
• Lemos J, Pereira D, Almendra L, et al. Distinct functional properties of the vertical and horizontal saccadic network in health and Parkinson’s disease: an eye-tracking and fMRI study. Brain Res. 2016;1648(Pt A):469–484. doi: 10.1016/j.brainres.2016.07.037
   PubMedGoogle Scholar
• Pa J, Dutt S, Mirsky JB, et al. The functional oculomotor network and saccadic cognitive control in healthy elders. Neuroimage. 2014;95:61–68. doi: 10.1016/j.neuroimage.2014.03.051
   PubMed Web of Science ®Google Scholar
• Ploner CJ, Gaymard BM, Rivaud-Péchoux S, et al. The prefrontal substrate of reflexive saccade inhibition in humans. Biological Psychiatry. 2005;57(10):1159–1165. doi: 10.1016/j.biopsych.2005.02.017
   PubMed Web of Science ®Google Scholar
• Ferreira MB, Pereira PA, Parreira M, et al. Relationships between neuropsychological and antisaccade measures in multiple sclerosis patients. PeerJ. 2018;6:e5737. doi: 10.7717/peerj.5737
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatric Psychiatry Neurol. 2010;23(3):151–157. doi: 10.1177/0891988710363714
   PubMedGoogle Scholar
• Arevalo-Rodriguez I, Smailagic N, Roqué IFM, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;2015(3):Cd010783. doi: 10.1002/14651858.CD010783.pub2
   PubMedGoogle Scholar
• Edelman JA, Valenzuela N, Barton JJ. Antisaccade velocity, but not latency, results from a lack of saccade visual guidance. Vision Res. 2006;46(8–9):1411–1421. doi: 10.1016/j.visres.2005.09.013
   PubMedGoogle Scholar
• Gao Y, Xu L, He N, et al. A narrative review of retinal vascular parameters and the applications (part II): diagnosis in stroke. Brain Circ. 2023;9(3):129–134. doi: 10.4103/bc.bc_9_23
   PubMedGoogle Scholar